Global pharma major Lupin Limited (Lupin) announced today the launch of its Satellite Laboratory in Vijayawada, Andhra Pradesh. The move is part of Lupin Diagnostics’ ongoing expansion aimed at enhancing access to high-quality testing services and increasing the diagnostics network across the country. The newly
Global pharma major Lupin Limited (Lupin) today announced
that it has received tentative approval from the United States Food and Drug Administration (FDA) for
its Abbreviated New Drug Application (ANDA), Drospirenone Tablets, 4 mg, to market a generic
equivalent of Slynd® Tablets, 4 mg, of Exeltis USA Inc.
Zydus, an innovation driven global pharma major and TLC, a specialty pharmaceutical company in Taiwan, today announced the signing of a license supply and commercialization agreement to commercialize AmphoTLC™ (Amphotericin B Liposome for Injection 50mg) in India. AmphoTLC™ is a critical drug to treat Mucormycosis